Fpa Clinical Research Kissimmee, FL - 34741

Fpa Clinical Research is categorized under Medical Research in Kissimmee, FL and active since 2005.

Fpa Clinical Research was established in 2005, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Christopher Chappel, Office Manager at the company’s single location by writing to 445 West Oak St, Kissimmee, Florida FL 34741 or by phoning (407) 846-6625. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Fpa Clinical Research
Contact Person: Christopher Chappel, Office Manager
Address: 445 West Oak St, Kissimmee, Florida 34741
Phone Number: (407) 846-6625
Website Address: fpaclinicalresearch.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Medical Research
SIC Code: 8733
NAICS Code: 6211110
Share This Business:

Fpa Clinical Research was started in 2005 to provide professional Medical Research under the SIC code 8733 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Christopher Chappel, Office Manager for inquiries that concern Fpa Clinical Research by calling the company number (407) 846-6625, as your correspondence is most welcome. Additionally, the physical location of the single location of Fpa Clinical Research can be found at the coordinates 28.30095,-81.40854 as well as the street address 445 West Oak St in Kissimmee, Florida 34741.

For its online presence, you may visit Fpa Clinical Research’s website at fpaclinicalresearch.com and engage with its social media outlets through on Twitter and on Facebook.